OPHTHALMIC SURGERY LASERS & IMAGING RETINA, cilt.46, sa.9, ss.942-948, 2015 (SCI-Expanded)
BACKGROUND AND OBJECTIVE: The major cause of failure in the management of retinoblastoma is the persistence/recurrence of vitreous seeds (VS). This study reports the efficacy and complications of standard lower-dose (20 mu g) intravitreal melphalan for VS.